Beth San Segundo is the CEO of OriGen Biomedical, a leading producer of cryopreservation, cell culture, and respiratory products that support the treatment of respiratory distress, cancer, genetic conditions, and other life-threatening diseases. Under Beth’s leadership, the company has thrived and sustained rapid growth. In this episode we get her thoughts on what it’s like to make products that are critical to healthcare, the current operating conditions impacting her business locally and globally, as well as what the future might hold for Origen and the regional medical device ecosystem, which in conjunction with the biopharmaceutical industry currently makes over a billion dollars in products every year.